Position in TEVA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,009
+$13,009 QoQ
Shares Held
384
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#578
of 675 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Jun 30, 2026CallValue
$2,541,000
CallShares
75,000
PutValue
$3,388,000
PutShares
100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PEAK6 LLC holds $6,524,525 across 3 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (0.2% of the industry book) .
All Filings in TEVA
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,541,000 | 75,000 | Call | Defined | 2026-08-13 | |
| 2026-06-30 | $3,388,000 | 100,000 | Put | Defined | 2026-08-13 | |
| 2026-06-30 | $13,009 | 384 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $608,424 | 20,200 | Call | Defined | 2026-05-14 | |
| 2026-03-31 | $3,012,000 | 100,000 | Put | Defined | 2026-05-14 | |
| 2025-12-31 | $3,121,000 | 100,000 | Put | Defined | 2026-03-12 | |
| 2025-12-31 | $29,711,920 | 952,000 | Call | Defined | 2026-03-12 | |
| 2025-09-30 | $96,212 | 4,763 | Shares | Defined | 2026-03-31 | |
| 2025-09-30 | $2,020,000 | 100,000 | Put | Defined | 2026-03-31 | |
| 2025-06-30 | $1,676,000 | 100,000 | Put | Defined | 2026-03-26 | |
| 2025-06-30 | $150,840 | 9,000 | Shares | Defined | 2026-03-26 | |
| 2024-12-31 | $989,596 | 44,900 | Call | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||